252 related articles for article (PubMed ID: 34140640)
1. Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types.
Li B; Pei G; Yao J; Ding Q; Jia P; Zhao Z
Oncogene; 2021 Jul; 40(28):4686-4694. PubMed ID: 34140640
[TBL] [Abstract][Full Text] [Related]
2. The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas.
Chen B; Chan WN; Xie F; Mui CW; Liu X; Cheung AHK; Lung RWM; Chow C; Zhang Z; Fang C; Yu P; Shi S; Zhou S; Chen G; Wang Z; Wang S; Ding X; Huang B; Liang L; Dong Y; Wong CC; Wu WKK; Cheng ASL; Wong N; Yu J; Lo KW; Tse GMK; Kang W; To KF
Clin Transl Med; 2023 Dec; 13(12):e1516. PubMed ID: 38148640
[TBL] [Abstract][Full Text] [Related]
3. The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes.
Thorlacius-Ussing J; Jensen C; Nissen NI; Cox TR; Kalluri R; Karsdal M; Willumsen N
J Pathol; 2024 Jan; 262(1):22-36. PubMed ID: 37728068
[TBL] [Abstract][Full Text] [Related]
4. Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma.
Hu B; Wu C; Mao H; Gu H; Dong H; Yan J; Qi Z; Yuan L; Dong Q; Long J
Ann Transl Med; 2022 Mar; 10(5):262. PubMed ID: 35402584
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
Front Immunol; 2022; 13():956224. PubMed ID: 36032075
[TBL] [Abstract][Full Text] [Related]
6. Targeting the devil: Strategies against cancer-associated fibroblasts in colorectal cancer.
Chen Y; Liang Z; Lai M
Transl Res; 2024 Aug; 270():81-93. PubMed ID: 38614213
[TBL] [Abstract][Full Text] [Related]
7. Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance.
Galbo PM; Zang X; Zheng D
Clin Cancer Res; 2021 May; 27(9):2636-2647. PubMed ID: 33622705
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analyses of the cancer-associated fibroblast subtypes and their score system for prediction of outcomes and immunosuppressive microenvironment in prostate cancer.
Gao Z; Zhang N; An B; Li D; Fang Z; Xu D
Cancer Cell Int; 2024 Apr; 24(1):127. PubMed ID: 38580966
[TBL] [Abstract][Full Text] [Related]
9. Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer.
Bagger MM; Sjölund J; Kim J; Kohler KT; Villadsen R; Jafari A; Kassem M; Pietras K; Rønnov-Jessen L; Petersen OW
Breast Cancer Res; 2024 Jan; 26(1):11. PubMed ID: 38229104
[TBL] [Abstract][Full Text] [Related]
10. A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer.
Zhang J; Chen M; Fang C; Luo P
Front Oncol; 2022; 12():1052132. PubMed ID: 36465388
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer.
Sebastian A; Hum NR; Martin KA; Gilmore SF; Peran I; Byers SW; Wheeler EK; Coleman MA; Loots GG
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455670
[TBL] [Abstract][Full Text] [Related]
12. Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway.
Licaj M; Mhaidly R; Kieffer Y; Croizer H; Bonneau C; Meng A; Djerroudi L; Mujangi-Ebeka K; Hocine HR; Bourachot B; Magagna I; Leclere R; Guyonnet L; Bohec M; Guérin C; Baulande S; Kamal M; Le Tourneau C; Lecuru F; Becette V; Rouzier R; Vincent-Salomon A; Gentric G; Mechta-Grigoriou F
Nat Commun; 2024 Feb; 15(1):1312. PubMed ID: 38346978
[TBL] [Abstract][Full Text] [Related]
13. Myofibroblastic cancer-associated fibroblast subtype heterogeneity in pancreatic cancer.
Kearney JF; Trembath HE; Chan PS; Morrison AB; Xu Y; Luan CF; McCabe IC; Zarmer SA; Kim HJ; Peng XL; Yeh JJ
J Surg Oncol; 2024 Apr; 129(5):860-868. PubMed ID: 38233984
[TBL] [Abstract][Full Text] [Related]
14. A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer.
Burley A; Rullan A; Wilkins A
Front Oncol; 2022; 12():1000888. PubMed ID: 36313650
[TBL] [Abstract][Full Text] [Related]
15. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer.
Ucaryilmaz Metin C; Ozcan G
BMC Cancer; 2022 Jun; 22(1):692. PubMed ID: 35739492
[TBL] [Abstract][Full Text] [Related]
17. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
[TBL] [Abstract][Full Text] [Related]
18. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
Zheng H; Liu H; Ge Y; Wang X
Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
[TBL] [Abstract][Full Text] [Related]
19. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature.
Herrera M; Islam AB; Herrera A; Martín P; García V; Silva J; Garcia JM; Salas C; Casal I; de Herreros AG; Bonilla F; Peña C
Clin Cancer Res; 2013 Nov; 19(21):5914-26. PubMed ID: 24052018
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer.
Croizer H; Mhaidly R; Kieffer Y; Gentric G; Djerroudi L; Leclere R; Pelon F; Robley C; Bohec M; Meng A; Meseure D; Romano E; Baulande S; Peltier A; Vincent-Salomon A; Mechta-Grigoriou F
Nat Commun; 2024 Apr; 15(1):2806. PubMed ID: 38561380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
